全文获取类型
收费全文 | 6761篇 |
免费 | 673篇 |
国内免费 | 28篇 |
专业分类
耳鼻咽喉 | 86篇 |
儿科学 | 156篇 |
妇产科学 | 361篇 |
基础医学 | 864篇 |
口腔科学 | 461篇 |
临床医学 | 1331篇 |
内科学 | 1290篇 |
皮肤病学 | 164篇 |
神经病学 | 343篇 |
特种医学 | 331篇 |
外科学 | 528篇 |
综合类 | 73篇 |
一般理论 | 1篇 |
预防医学 | 628篇 |
眼科学 | 90篇 |
药学 | 475篇 |
中国医学 | 66篇 |
肿瘤学 | 214篇 |
出版年
2023年 | 104篇 |
2022年 | 131篇 |
2021年 | 241篇 |
2020年 | 170篇 |
2019年 | 205篇 |
2018年 | 264篇 |
2017年 | 236篇 |
2016年 | 235篇 |
2015年 | 310篇 |
2014年 | 333篇 |
2013年 | 388篇 |
2012年 | 427篇 |
2011年 | 491篇 |
2010年 | 301篇 |
2009年 | 286篇 |
2008年 | 330篇 |
2007年 | 311篇 |
2006年 | 286篇 |
2005年 | 244篇 |
2004年 | 185篇 |
2003年 | 199篇 |
2002年 | 153篇 |
2001年 | 134篇 |
2000年 | 110篇 |
1999年 | 119篇 |
1998年 | 130篇 |
1997年 | 130篇 |
1996年 | 117篇 |
1995年 | 107篇 |
1994年 | 80篇 |
1993年 | 60篇 |
1992年 | 54篇 |
1991年 | 78篇 |
1990年 | 30篇 |
1989年 | 51篇 |
1988年 | 54篇 |
1987年 | 31篇 |
1986年 | 41篇 |
1985年 | 43篇 |
1984年 | 20篇 |
1983年 | 25篇 |
1982年 | 25篇 |
1981年 | 12篇 |
1980年 | 18篇 |
1978年 | 26篇 |
1977年 | 19篇 |
1976年 | 21篇 |
1975年 | 15篇 |
1974年 | 10篇 |
1969年 | 10篇 |
排序方式: 共有7462条查询结果,搜索用时 15 毫秒
81.
Cludia Pina Costa Joo Nuno Moreira Jos Manuel Sousa Lobo Ana Catarina Silva 《药学学报(英文版)》2021,11(4):925
The management of the central nervous system (CNS) disorders is challenging, due to the need of drugs to cross the blood‒brain barrier (BBB) and reach the brain. Among the various strategies that have been studied to circumvent this challenge, the use of the intranasal route to transport drugs from the nose directly to the brain has been showing promising results. In addition, the encapsulation of the drugs in lipid-based nanocarriers, such as solid lipid nanoparticles (SLNs), nanostructured lipid carriers (NLCs) or nanoemulsions (NEs), can improve nose-to-brain transport by increasing the bioavailability and site-specific delivery. This review provides the state-of-the-art of in vivo studies with lipid-based nanocarriers (SLNs, NLCs and NEs) for nose-to-brain delivery. Based on the literature available from the past two years, we present an insight into the different mechanisms that drugs can follow to reach the brain after intranasal administration. The results of pharmacokinetic and pharmacodynamics studies are reported and a critical analysis of the differences between the anatomy of the nasal cavity of the different animal species used in in vivo studies is carried out. Although the exact mechanism of drug transport from the nose to the brain is not fully understood and its effectiveness in humans is unclear, it appears that the intranasal route together with the use of NLCs, SLNs or NEs is advantageous for targeting drugs to the brain. These systems have been shown to be more effective for nose-to-brain delivery than other routes or formulations with non-encapsulated drugs, so they are expected to be approved by regulatory authorities in the coming years.KEY WORDS: Nose-to-brain delivery, Intranasal administration, Nanostructured lipid carriers, NLC, Solid lipid nanoparticles, SLN, Nanoemulsions, In vivo studies, Pharmacokinetic, Pharmacodynamics 相似文献
82.
83.
K. L. Ferrazzo M. M. Neto E. dos Santos D. dos Santos Pinto S. O. M. de Sousa 《Journal of oral pathology & medicine》2009,38(9):701-707
Background: Galectin-3 has been implicated in tumor progression of some malignancies as thyroid, prostate, and salivary gland tumors. Recently, it has been suggested that this protein may be an important mediator of the β-catenin/Wnt pathway. Moreover, nuclear galectin-3 expression has been implicated in cell proliferation, promoting cyclin D1 activation. Thus, the present study aimed to correlate galectin-3 expression with β-catenin and cyclin D1 expressions in adenoid cystic carcinoma (ACC) and in polymorphous low-grade adenocarcinoma (PLGA).
Methods: Fifteen formalin-fixed paraffin-embedded cases of each tumor were retrieved from the files of the Surgical Oral Pathology Service at the University of São Paulo and the proteins were analyzed by immunohistochemistry.
Results: Adenoid cystic carcinoma showed galectin-3 immunostaining mainly in the nuclei, while PLGA revealed a positive mostly cytoplasmic reaction to galectin-3 in the largest part of tumor cells. Both tumors showed intense cytoplasmic/nuclear staining for β-catenin in majority of cases. Cyclin D1 immunoreactivity was not detected in 14/15 PLGA and showed specific nuclear staining in 10/15 cases of ACC in more than 5% of the neoplastic cells. Cyclin D1 expression was correlated with cytoplasmic and nuclear galectin-3 expression in ACC ( P < 0.05).
Conclusions: These results suggest that in ACC galectin-3 may play a role in cellular proliferation through cyclin D1 activation. In addition, nuclear expression of galectin-3 in ACC may be related to a more aggressive behavior of this lesion. Although β-catenin seems to play a role in carcinogenesis in both lesions, it seems that it does not bind to galectin-3 for cyclin D1 stimulation. 相似文献
Methods: Fifteen formalin-fixed paraffin-embedded cases of each tumor were retrieved from the files of the Surgical Oral Pathology Service at the University of São Paulo and the proteins were analyzed by immunohistochemistry.
Results: Adenoid cystic carcinoma showed galectin-3 immunostaining mainly in the nuclei, while PLGA revealed a positive mostly cytoplasmic reaction to galectin-3 in the largest part of tumor cells. Both tumors showed intense cytoplasmic/nuclear staining for β-catenin in majority of cases. Cyclin D1 immunoreactivity was not detected in 14/15 PLGA and showed specific nuclear staining in 10/15 cases of ACC in more than 5% of the neoplastic cells. Cyclin D1 expression was correlated with cytoplasmic and nuclear galectin-3 expression in ACC ( P < 0.05).
Conclusions: These results suggest that in ACC galectin-3 may play a role in cellular proliferation through cyclin D1 activation. In addition, nuclear expression of galectin-3 in ACC may be related to a more aggressive behavior of this lesion. Although β-catenin seems to play a role in carcinogenesis in both lesions, it seems that it does not bind to galectin-3 for cyclin D1 stimulation. 相似文献
84.
Dr. M. Tavares de Sousa A. Bernhardt E. Rückert B. Hüneke K. Hecher 《Der Gyn?kologe》2009,42(8):633-635
Breast abscesses in lactating women can result as a complication of mastitis, especially if treatment is delayed or inadequate. The reported incidence is up to 20%. Needle aspiration under ultrasound guidance has great value in the treatment of breast abscesses, even in lesions with a large volume. With a good cosmetic outcome, this method is likely to be well accepted as an alternative to surgical treatment. 相似文献
85.
86.
87.
Libani IV Guy EC Melchiori L Schiro R Ramos P Breda L Scholzen T Chadburn A Liu Y Kernbach M Baron-Lühr B Porotto M de Sousa M Rachmilewitz EA Hood JD Cappellini MD Giardina PJ Grady RW Gerdes J Rivella S 《Blood》2008,112(3):875-885
In β-thalassemia, the mechanism driving ineffective erythropoiesis (IE) is insufficiently understood. We analyzed mice affected by β-thalassemia and observed, unexpectedly, a relatively small increase in apoptosis of their erythroid cells compared with healthy mice. Therefore, we sought to determine whether IE could also be characterized by limited erythroid cell differentiation. In thalassemic mice, we observed that a greater than normal percentage of erythroid cells was in S-phase, exhibiting an erythroblast-like morphology. Thalassemic cells were associated with expression of cell cycle–promoting genes such as EpoR, Jak2, Cyclin-A, Cdk2, and Ki-67 and the antiapoptotic protein Bcl-XL. The cells also differentiated less than normal erythroid ones in vitro. To investigate whether Jak2 could be responsible for the limited cell differentiation, we administered a Jak2 inhibitor, TG101209, to healthy and thalassemic mice. Exposure to TG101209 dramatically decreased the spleen size but also affected anemia. Although our data do not exclude a role for apoptosis in IE, we propose that expansion of the erythroid pool followed by limited cell differentiation exacerbates IE in thalassemia. In addition, these results suggest that use of Jak2 inhibitors has the potential to profoundly change the management of this disorder. 相似文献
88.
Sousa Rd França A Dória Nòbrega S Belo A Amaro M Abreu T Poças J Proença P Vaz J Torgal J Bacellar F Ismail N Walker DH 《The Journal of infectious diseases》2008,198(4):576-585
BACKGROUND: The pathophysiologic mechanisms that determine the severity of Mediterranean spotted fever (MSF) and the host-related and microbe-related risk factors for a fatal outcome are incompletely understood. METHODS: This prospective study used univariate and multivariate analyses to determine the risk factors for a fatal outcome for 140 patients with Rickettsia conorii infection admitted to 13 Portuguese hospitals during 1994-2006 with documented identification of the rickettsial strain causing their infection. RESULTS: A total of 71 patients (51%) were infected with the Malish strain of Rickettsia conorii, and 69 (49%) were infected with the Israeli spotted fever (ISF) strain. Patients were admitted to the intensive care unit (40 [29%]), hospitalized as routine inpatients (95[67%]), or managed as outpatients (5[4%]). Death occurred in 29 adults (21%). A fatal outcome was significantly more likely for patients infected with the ISF strain, and alcoholism was a risk factor. The pathophysiology of a fatal outcome involved significantly greater incidence of petechial rash, gastrointestinal symptoms, obtundation and/or confusion, dehydration, tachypnea, hepatomegaly, leukocytosis, coagulopathy, azotemia, hyperbilirubinemia, and elevated levels of hepatic enzymes and creatine kinase. Some, but not all, of these findings were observed more often in ISF strain-infected patients. CONCLUSIONS: Although fatalities and similar clinical manifestations occurred among both groups of patients, the ISF strain was more virulent than the Malish strain. Multivariate analysis revealed that acute renal failure and hyperbilirubinemia were most strongly associated with a fatal outcome. 相似文献
89.
90.